KNSA
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
KNSA Stock Analysis: Buy, Sell, or Hold?
$95.76
+0.74 (+0.78%)
▲
5d:
-0.37%
30d:
+21.94%
90d:
+23.04%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 27, 2026
0d
Protect KNSA Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (40%)
Quality Score
45/100
Position
EXTENDED
30-Day Fair Range
$77.17 – $93.11
Position: EXTENDED
Forward P/E & Valuation
43.9x
STRETCHED
vs 34.4x historical avg
Wall Street Target
$109.43
+14.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$87.30 / $99.31
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: KNSA shows conflicting indicators. Wait for confirmation before entering.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 10, 2026 at $94.79 · last confirmed Nov 11, 2026
Strength: 5.5/10
Get Alerted When KNSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$106.25
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$65.97
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: KNSA is currently trading at $95.76, which is considered extended relative to its 30-day fair value range of $77.17 to $93.11. From a valuation perspective, the stock is trading at a premium (Forward PE: 43.9) compared to its historical average (34.4). At these levels, the market is pricing in 8.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, KNSA is in a strong uptrend. Immediate support is located at $87.30, while resistance sits at $99.31.
Market Sentiment: KNSA scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $109.43 (+14.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KNSA is in a strong uptrend. Immediate support is located at $87.30, while resistance sits at $99.31.
Market Sentiment: KNSA scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $109.43 (+14.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$77.17 -
$93.11
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.4%
Trading Range & Key Levels
30-Day Trading Range
$77.17 -
$93.11
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$8.36
(8.7%)
Support Level
$87.30
Resistance Level
$99.31
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding KNSA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($109.43)
- NEUTRAL: PE elevated vs history but 8.4% growth expectation is conservative given 144% recent growth
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
43.88
Wall Street Target
$109.43
(+14.3%)
Revenue Growth (YoY)
58.1%
Earnings Growth (YoY)
143.5%
Profit Margin
11.6%
Valuation Premium vs History
+8.4% premium
PE vs Historical
43.9 vs 34.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.4%
(market-implied from PE analysis)
1-Year Target
$103.80
(+8%)
2-Year Target
$112.52
(+18%)
3-Year Target
$121.98
(+27%)
3-Yr Target (if PE normalizes)
(PE: 44→34)
PE COMPRESSION
$95.63
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 43.9, Growth: 46.0%)
$297.94
(+211%)
Base:
(SPY PE: 19.9, Growth: 46.0%)
$134.86
(+41%)
Bear:
(PE: 16.9, Growth: 46.0%)
$114.63
(+20%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (75x PE), but valuation improves significantly next year (44x PE) as earnings recover.
Trailing PE: 74.82 | Current EPS (TTM): $1.27
Bull Case
$179.62
(+88%)
Analyst growth 71.9%, PE expands to 82.3
Base Case
$163.29
(+71%)
Market implied 71.9%, PE stable at 74.8
Bear Case
$64.61
(-33%)
Severe decline -20.0%, PE contracts to 63.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share KNSA Analysis
Share this live KNSA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (KNSA)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Oct 27, 2026
Daily AI digest
AI Retail Discussion Summary:
Investors express bullish sentiment towards $KNSA following the release of strong Q2 earnings results. The company reported an EPS of $0.56, surpassing expectations by $0.19, and revenue of $286M, beating estimates by $25M.
Key Retail Themes:
earnings beat
strong financial performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:53 AM ET
Data refreshes hourly during market hours. Next update: 2:53 AM
Data refreshes hourly during market hours. Next update: 2:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KNSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Advanced KNSA Option Strategies
Professional options setups generated by AI based on today's KNSA price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive KNSA Research Pages
